VJHemOnc Podcast iwMyeloma Session I: genomics of high-risk and smoldering multiple myeloma
Apr 12, 2023
Leif Bergsagel, MD, Mayo Clinic, Phoenix, AZ, and Francesco Maura, MD, Sylvester Comprehensive Cancer Center, discuss genomics of high-risk and smoldering multiple myeloma. Topics cover next-generation sequencing (NGS), del(17p) and TP53 mutations, high-risk factors, controversy surrounding 17P deletion and TP53 mutation, challenges in determining and targeting cancer cells.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Cell Progression and Transition to Next-Generation Sequencing in Myeloma Study
01:45 • 2min
Understanding High-Risk Factors in Multiple Myeloma Patients
03:22 • 2min
Controversy and Risk Assessment in 17P Deletion and TP53 Mutation in Multiple Myeloma
05:41 • 3min
Challenges in Determining and Targeting Cancer Cells
08:30 • 5min